Target intelligence / Profile preview

Calcium-binding protein 2 (CaBP2)

Target
CaBP2
Molecular classification
Other (EF-hand calcium-binding protein), Calcium signaling protein
01

Overview

Calcium-binding protein 2 (CaBP2) is a member of the EF-hand calcium-binding protein family that regulates neuronal calcium signaling, especially in the auditory system[1][2][3]. It is structurally related to calmodulin but exhibits more brain- and retina-enriched expression patterns. CaBP2 is highly expressed in inner hair cells of the cochlea, where it helps to sustain synaptic transmission crucial for sound encoding by attenuating voltage- and calcium-dependent inactivation of L-type calcium channels, particularly CaV1.3[2][3]. Loss-of-function mutations in CABP2 cause autosomal recessive nonsyndromic hearing loss (DFNB93), but it is not currently a therapeutic drug target[3].

Other names
CABP2CaBP2DFNB93
02

Mechanism of action

Not therapeutically targeted; endogenous mechanism is inhibition of calcium channel inactivation, supporting sustained calcium influx and synaptic transmission[2][3].

03

Biological functions

Modulates calcium signalingRegulates inactivation of voltage-gated calcium channels (notably CaV1.3)Facilitates sustained neurotransmission at auditory inner hair cell ribbon synapses
04

Disease associations

Other (Hereditary deafness / Sensorineural hearing loss; specifically, DFNB93 nonsyndromic deafness)
05

Safety considerations

No information available; not a therapeutic target
06

Interacting drugs

None known
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Calcium-binding protein 2 (CaBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium-binding protein 2 (CaBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call